Lovastatin and cholesterol cream for DSAP

Cholesterol and Lovastatin Cream for DSAP

Disseminated Superficial Actinic Porokeratosis (DSAP) is a common skin condition that causes multiple rough, scaly rings or patches on sun-exposed areas, particularly the arms and legs. Although DSAP is usually harmless, it can be cosmetically troublesome and may continue to spread over time. Traditional treatments such as cryotherapy, topical creams, laser treatment and photodynamic therapy are rarely helpful.

A newer treatment approach uses a combination of cholesterol and lovastatin applied directly to the skin. This treatment is based on recent discoveries about the underlying cause of DSAP and aims to address the disease process itself rather than simply treating the visible lesions.

Why does DSAP develop?

DSAP is usually caused by inherited mutations in genes involved in the mevalonate pathway. This pathway is responsible for producing cholesterol and other important molecules that help maintain normal skin function.

When these genes do not work properly, two problems may occur. First, the skin may not produce enough cholesterol to maintain a healthy skin barrier. Second, potentially harmful intermediate molecules may accumulate within skin cells.

These abnormalities can lead to the formation of the characteristic DSAP lesions.

How does cholesterol and lovastatin work?

The combination treatment is designed to correct both aspects of the underlying problem.

Cholesterol helps replace the cholesterol that the skin may be lacking, supporting normal skin barrier function. Lovastatin blocks an earlier step in the mevalonate pathway, reducing the build-up of potentially toxic intermediate substances that may contribute to lesion formation.

This approach targets the biological mechanism responsible for DSAP rather than simply reducing inflammation or destroying abnormal skin.

How effective is it?

Several studies have shown encouraging results.

Many patients experience smoother skin, less scaling, reduced redness, and fading of existing lesions. Improvement typically develops gradually over several weeks to months. Complete clearance is uncommon, but many patients report a noticeable improvement in the appearance and feel of their skin.

Some studies have found that lovastatin combined with cholesterol performs better than cholesterol alone. More recently, there is evidence that lovastatin by itself may also be effective in some patients.

How is it used?

The treatment is usually prepared by a specialist compounding pharmacy.

Typical formulations contain:

The cream is generally applied once or twice daily to affected areas.

Treatment often needs to continue for several months before the full benefit becomes apparent.

Is it safe?

Because the medication is applied to the skin, absorption into the bloodstream is very low. Reported side effects are usually mild and may include temporary irritation, redness, dryness, or stinging when first applied.

Serious side effects associated with oral statin medications are very unlikely with topical treatment.

Can I use oral statins instead?

Some patients with DSAP already take oral statins such as atorvastatin, rosuvastatin, or simvastatin for cholesterol control. Unfortunately, taking statin tablets does not appear to improve DSAP.

The benefit appears to come from applying lovastatin directly to the affected skin rather than taking a statin by mouth.

Does cholesterol and lovastatin cure DSAP?

No treatment currently cures DSAP permanently. However, cholesterol and lovastatin cream is one of the most promising treatments available because it targets the underlying disease mechanism.

Many dermatologists now consider it a reasonable treatment option for patients with extensive DSAP, particularly when conventional treatments have been unsuccessful.

How can I help?

I can usually make a diagnosis of DSAP on the basis of the appearances. Occasionally a biopsy may be required to confirm the diagnosis or exclude other conditions.

If cholesterol and lovastatin cream is appropriate for you, I can arrange a prescription through a specialist compounding pharmacy.

Dr. Magnus Lynch, Consultant Dermatologist

About Dr Magnus Lynch

I am a London-based Consultant Dermatologist and Dermatological Surgeon. I am highly experienced in skin cancer diagnosis, Mohs micrographic surgery, acne, rosacea, acne scarring and laser treatments. I studied at the Universities of Cambridge and Oxford, and completed my dermatology training and Mohs fellowship at the prestigious St John’s Institute of Dermatology. I graduated from medical school in 2003 and have worked exclusively in Dermatology since 2012.

I lead a research team at King’s College London investigating the molecular biology of skin cancer. In recent years I have been involved in Media Appearances, including the Channel 5 series 'Skin A&E', where I perform skin surgeries and treat various skin conditions. Filming for the next series has recently completed and the series will be released later in 2025.

My NHS practice is at Guy's Hospital. I consult with private patients at the London Bridge Hospital, OneWelbeck (near to Bond Street station) and on Harley Street. A new consultation is £250. Book A Consultation.

Back to home